Protagonist Therapeutics (PTGX) Treasury Shares (2015 - 2025)
Protagonist Therapeutics (PTGX) posted Treasury Shares of $1.3 million for Q4 2025, up 1607.09% sequentially from $75500.0 in Q4 2024, and up 1607.09% YoY from $75500.0 in Q4 2024.
Protagonist Therapeutics (PTGX) Treasury Shares (2015 - 2025) Analysis & Trends
Protagonist Therapeutics has reported Treasury Shares for 6 years, with the latest figure at $1.3 million in Q4 2025.
- Quarterly Treasury Shares rose 1607.09% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (up 1607.09% YoY) and the FY2025 annual result came in at $1.3 million, up 1607.09% from the prior year.
- Treasury Shares rose to $1.3 million in Q4 2025 per PTGX's latest filing, from $75500.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $1.3 million in Q4 2025 and troughed at $75500.0 in Q4 2024.
- A 4-year average of $630721.2 and a median of $679452.5 in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2023 and 2025: Treasury Shares plunged 88.84% in 2023, then surged 1607.09% in 2025.
- Over 4 years, Treasury Shares stood at $694414.0 in 2022, then declined by 4.31% to $664491.0 in 2023, then tumbled by 88.64% to $75500.0 in 2024, then soared by 1607.09% to $1.3 million in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $1.3 million, $75500.0, and $664491.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Protagonist Therapeutics | 10.03 Bn | 10.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.29 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 75,500.00 |
| Dec 31, 2024 | 75,500.00 |
| Dec 31, 2023 | 664,491.00 |
| Dec 31, 2023 | 664,491.00 |
| Jun 30, 2023 | 85,500.00 |
| Jun 30, 2023 | 85,500.00 |
| Mar 31, 2023 | 864,112.00 |
| Mar 31, 2023 | 864,112.00 |
| Sep 30, 2022 | 694,414.00 |
| Sep 30, 2022 | 694,414.00 |
| Jun 30, 2022 | 766,090.00 |
| Jun 30, 2022 | 766,090.00 |
| Mar 31, 2022 | 606,810.00 |
| Mar 31, 2022 | 606,810.00 |
| Jun 30, 2016 | 124.37 Mn |
| Jun 30, 2016 | 124.37 Mn |
| Mar 31, 2016 | 2.00 Mn |
| Mar 31, 2016 | 2.00 Mn |